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ABSTRACT: orphans are a subpopulation with 
a unique set of additional vulnerabilities. Increasing 
focus on children’s rights, pediatric global health, and 
pediatric research makes it imperative to recognize and 
address unique vulnerabilities of orphaned children. 
This paper describes the unique vulnerabilities of the 
orphaned pediatric population and offers a structured 
set of factors that require consideration when including 
orphans in biomedical research. Pediatric orphans are 
particularly vulnerable due to decreased economic 
resources, psychosocial instability, increased risk of 
abuse, and delayed/decreased access to healthcare. These 
vulnerabilities are significant. By carefully considering 
each issue in a population in a culturally specific and 
study-specific manner, researchers can make valuable 
contributions to the overall health and well-being of this 
uniquely vulnerable population. 
KEY WORDS: orphan, vulnerability, research, HIV, 
Kenya
Received: June 21, 2012; Revised: September 12, 2012
Populations can be defined as “vulnerable” using various parameters (Levine et al., 2004). Participants may be vulnerable due to socioeco-
nomic status, age, gender, or simply the timing of the par-
ticular study as may occur in times of catastrophic illness, 
natural disasters, and political upheaval. Most regulatory 
and oversight documents for research involving human 
subjects obligate researchers to provide additional protec-
tions to vulnerable populations. For example, in the United 
States additional protections are specifically described for 
prisoners, pregnant women and fetuses, and children (US 
Department of Health and Human Services, n.d.). The 
ethical and legal obligation to provide additional protec-
tions to vulnerable subjects is derived from recognized 
principles of bioethics, including those three initially 
described in the Belmont Report: respect for persons, jus-
tice, and beneficence (US Department of Health and 
Human Services, 1979). Refinements to these principles, 
for example by Beauchamp and Childress, have enjoyed 
support, and are also reflected in major international guid-
ance documents including the Declaration of Helsinki 
(Beauchamp, 2009). The common ethical commitment 
found in all protections of vulnerable research subjects is to 
protect those incapable of protecting themselves against 
harm or exploitation.
But context and geography matter. Despite the empha-
sis on these protections, challenges arise as researchers 
begin to include increasingly vulnerable populations, 
such as African children, in their studies. Even though 
ethical principles may enjoy support, their local interpre-
tation matters. Basic definitions of who comprises a 
population such as “orphaned children” may be a source 
of contention, while other definitions such as children as 
a vulnerable population may not be universally accepted.
Kipnis (2003) has described seven specific vulnerabili-
ties of the pediatric population, including the possible 
undervaluing of their rights and interests in society and 
the subjugation of their authority to others (Figure 1). The 
ethical obligation to protect vulnerable pediatric research 
participants from harm is met largely through two mech-
anisms: (1) the additional protections that institutional 
review boards may impose on researchers, and (2) the 
involvement of legally authorized representatives—most 
often a parent or guardian to act in the participant’s best 
interests. But what should happen when parents or guard-
ians do not exist? Orphaned children have no such advo-
cates, and therefore no one to act in their best interests. 
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It is unclear how to ensure adequate protection for this vul-
nerable population, and raises the question of whether orphans 
should be included in health research at all. The necessity 
requirement dictates that vulnerable individuals should be 
included only if one could not do the research using less vul-
nerable populations. Additionally, the subject requirement 
demands that the research addresses a question that is unique 
to the vulnerable population. Following these requirements 
might result in the exclusion of children from research, to the 
detriment of the pediatric population. Although this may seem 
protective, there are many important reasons to include chil-
dren in research. For example, across the developmental spec-
trum from infancy through adolescence, children have 
different physiologic and metabolic profiles that influence the 
effects of a medication, making it imperative to evaluate med-
ications in children and not just in adults. Similarly, the orphan 
population should not be summarily dismissed from biomed-
ical research. Orphans face particular physical, social, and 
emotional challenges, for which the effects and solutions may 
only be illuminated if research is conducted in this particular 
population. Both the necessity and the subject requirements 
should be carefully considered and applied to each new proto-
col involving orphans. As orphans are subject to a substantial 
share of health burdens, researchers may also find that the 
principle of justice directs us to answer important questions to 
improve the health and care of the 132 million orphans in sub-
Saharan Africa, Asia, Latin America, and the Caribbean 
(UNICEF, 2009). 
A Theoretical Case Study in the Vulnerabilities of Orphans 
in Research Ethics
Consider a theoretical case of a proposed HIV vaccine 
trial in rural Kenya. Consideration of this case will 
serve as a springboard to conduct a critical review of 
the participation of orphans in health research, and 
then yield a series of distinct factors that must be con-
sidered for the participation of orphans in biomedical 
and behavioral research. 
Prevalence of orPhanhood demands consideration  
for health research
HIV vaccine research has, to date, excluded children from 
clinical trials. If researchers were to pursue a clinical trial 
including children in Kenya, the involvement or exclusion 
of orphaned or vulnerable children would be critical to the 
study design. As the HIV epidemic continues in Africa, 
mortality rates from HIV/AIDS are expected to continue 
to rise, and the number of children orphaned will continue 
to increase exponentially (Subbarao & Coury, 2004). In 
sub-Saharan Africa, there are an estimated 53 million 
orphans, with over a quarter orphaned by HIV/AIDS 
(UNICEF, 2006). Kenya has an estimated population of 
greater than 39 million people, including an estimated 2.5 
million orphans, almost half of whom have been orphaned 
by the HIV/AIDS epidemic (UNICEF, 2006; Kenya 
National Bureau of Statistics, 2010). The sizeable popula-
tion of children orphaned from HIV and other causes 
argues for the inclusion of this population in biomedical 
and behavioral research. In addition to the general size of 
this population, the large number of orphans whose lives 
have been affected by HIV and who may be at higher risk 
for HIV positions them as relevant subjects. Guidelines do 
suggest that individuals, such as wards of the state, identi-
fied as vulnerable should not be eligible to participate in 
research that represents more than greater than minimal 
risk (US Department of Health and Human Services, 
n.d.). While it is imperative to ensure the safety of the 
study population, it is also irresponsible to summarily 
dismiss a group of individuals without consideration of 
potential benefit/harm ratios. The definition of minimal 
risk may vary based on the risks inherent in the group’s 
everyday life. And even the identification of a group as 
vulnerable or the definition of the term “vulnerable” may 
require reconsideration. Levine et al. (2004) argue that 
vulnerability can be both too broadly and too narrowly 
defined and propose that contextual interpretation of vul-
nerability should be applied to individuals and groups. 
Similarly, Shivas (2004) argues that almost all humans can 
be considered vulnerable in research; however, it is the 
context of each study by which we should assess potential 
harm. Analysis protocol by protocol for vulnerability and 
risk, as opposed to blanket groupings of “vulnerability,” 
ensures that individual and contextual elements are con-
sidered. Although minimal risk may be present, it is 
important to consider the broader context of the proce-
dure to assess for individual vulnerabilities and potential 
benefits. In order to safely include orphans in research, 
their unique population vulnerabilities must be directly 
addressed in a thoughtful and comprehensive manner. 
Examining three categories of vulnerability—socioeco-
nomic, psychosocial, and medical—experienced by 
orphaned children in Kenya participating in an HIV 
Fig. 1. Kipnis’s seven vulnerabilities.
Seven Vulnerabilities of Pediatric Populations
(1) Commonly lack the capacity to make mature decisions
(2) Subject to authority of others
(3) They may be deferential in ways that mask underlying 
dissent
(4) Their rights and interests may be socially undervalued
(5) They may have acute medical conditions requiring 
immediate decisions not consistent with informed consent
(6) They may have serious medical conditions that cannot be 
effectively treated
(7) They may lack important socially distributed goods
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vaccine trial will provide a lens through which to consider 
the ethical considerations when involving orphans in bio-
medical research. 
Case Study
We will consider an HIV vaccine trial that would consist 
of a nonviral vaccination that is given in a two-part 
series. The trial seeks to enroll Kenyan participants of 
ages 18 months to 18 years. The study would be con-
ducted in the north Rift Valley and western Kenyan 
provinces in a large/moderate-sized city with a large hos-
pital and surrounding satellite clinics. Participants will be 
recruited from schools, health centers, the Moi Teaching 
and Referral Hospital, and local organizations. A small 
financial incentive covering the cost of travel to clinic 
visits will be provided for all participants. Any partici-
pant who comes to a recruitment session will also be 
reimbursed for travel costs (no more than 400 Ksh/visit). 
During the study, participants would be required to pro-
vide a list of all members of the household and proof of 
custody of that child. Orphans are defined as any child 
under the age of 18 where either parent or both parents 
are deceased (UNICEF, 2009). Each participant’s status 
as to orphan, double orphan, or custody arrangement 
would be noted. Prior to enrollment in the study, par-
ticipants would be invited to discuss the study and con-
sent in a private environment. 
Complete physical exam and mental health screening will 
be conducted upon enrollment in the study. In addition, each 
participant will have preliminary testing for HIV and will be 
retested to ensure seronegative status in accordance with age-
appropriate guidelines. Participants enrolled in the study will 
be followed by a local clinic in Kenya for the duration of the 
vaccine series and for five years after the vaccinations, with 
six-month testing for HIV infection and three-month follow-
up visits during the intervals between vaccinations to assess 
the children’s general health status. Parents and guardians will 
be reminded of each visit with cards and phone calls prior to 
each visit. Two copies of color-blocked cards with medication 
schedules and visits will be provided to each participant. Case 
participants will receive the vaccine, and a matched control 
cohort will be followed prospectively from the same clinic. 
Socio-economic Vulnerabilities of Orphaned Children in 
Health Research
There are three central socioeconomic vulnerabilities of 
orphaned children: their baseline socioeconomic sta-
tus, educational status of caregivers, and particular 
economic deprivations for subpopulations that vary by 
location (Table 1). 
socio-economic status
First, the baseline economic status of the orphan popula-
tion should be assessed. Most orphans in sub-Saharan 
Africa live in poorer households than non-orphans, and 
their care tends to fall on poorer homes headed by the 
elderly or by women (Case, Paxson, & Ableidinger, 2002). 
A lack of material wealth places orphaned children at 
increased risk of poorer health and well-being, but also at 
increased risk in terms of participation in biomedical 
TABLE 1.  socioeconomic vulnerabilities of orphans.
issue Background
ethical concerns for  
research
Kenya-specific  
issues Potential intervention
Baseline 
Socio-
economic 
Status
Orphans live in poorer 
households than non-
orphans (REFS)
Even a small amount of 
money could be coercive 
for families who have little 
or nothing  
Cultural awareness 
of expectations
• Outline clear expectations at be-
ginning of study using handouts, 
video, or pictorial guides
• Community assent to proposed 
study
Education Orphan caregivers 
likely to have lower 
levels of education
Lower literacy and numeracy 
mean study goals and 
procedures may not be 
understood
• Multiple local 
dialects
• Uneven literacy 
rates
• Concept of being 
“taken”
• Translators with skills in common 
and vernacular languages
• Handouts using pictures, common 
and vernacular language, and 
simple sentence structure/ 
vocabulary
Subpopulation 
Specifics
Specific subpopula-
tions such as double 
orphans are at 
uniquely higher risk 
for financial strain
How do you identify, protect, 
and appropriately include 
these populations?
• Property snatching 
from women and 
children
• Lack of laws and 
rights protect-
ing vulnerable 
subpopulations
• Awareness of cultural context 
of your study, including social 
stressors that may not be appar-
ent to outside observers
• Consider qualitative inquiry to fur-
ther understand specific context 
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research. Their increased poverty may make them more 
susceptible to pressure to participate in studies because of 
the incentives or perceived benefits they may receive. 
Orphaned children, or their caregivers, may feel compelled 
to participate in research in order for their caregivers to 
receive even small monetary incentives that are not com-
pelling for families with more resources. Researchers must 
investigate the baseline status for their population and give 
special consideration to providing appropriate incentives 
for study participation without inadvertent economic coer-
cion of orphans or their family units. Community expecta-
tions and perceptions are significant in evaluating an 
approach to study recruitment and participation. If research 
has been conducted in the community before, precon-
ceived ideas about compensation, care, or level of involve-
ment may already exist. While the lower socioeconomic 
status might render these families more vulnerable to being 
influenced by financial incentives, it also creates health 
vulnerabilities for the orphans. These children’s increased 
health risks are an important reason to include them in 
biomedical research with the potential to benefit their 
health, yet they might also be susceptible to participation in 
research to gain access to healthcare and other services.
Case Ethics
A potential first strategy for investigators would be to 
conduct online research using worldwide databases to 
investigate the economic status of the countries of inter-
est. To contextualize this economic information for a 
particular setting, the researcher could then have conver-
sations with key community members to verify that the 
study is appropriate for the given community and that 
proposed incentives are appropriate in accordance with 
the local economic climate. Community leaders would be 
a valuable resource for discussions of possible complica-
tions and provide introductions to facilitate a discussion 
with the whole community. Researchers should consider 
community discussions as a form of community assent 
for study participation (Naanyu et al., 2011).
education
Frequently, the caregivers responsible for protecting the 
interests of orphaned children may themselves have only 
a rudimentary education, speak primarily in local dialect, 
or be unable to read and write. Delineation of the scope 
of the research study can be a frustrating communication 
challenge. Limited education may make it difficult for 
participants to understand and weigh the concepts of 
risks and benefits. Lack of numeracy makes it more dif-
ficult to decide whether a risk is significant. Perceived or 
real increased access to healthcare as part of research 
participation can often act as an independent benefit in 
the caretaker or child’s rationalization process. In eco-
nomically limited countries where numerous NGOs and 
other charitable organizations exist, caretakers may have 
the expectation that the child will be “taken,” and this 
needs to be clarified in the context of the study. In Kenya, 
many caregivers may believe that participation with a 
research study or nonprofit organization means that the 
child will also be “taken,” meaning a charitable organiza-
tion will house, provide food for, and/or educate orphans, 
sometimes in conjunction with research studies provid-
ing healthcare (Nyambedha, 2008). The possibility of an 
orphan being taken is often an implied benefit in the 
mind of the caretaker, and so researchers must carefully 
delineate the scope of care to be provided before and after 
study participation (ibid.). A study involving orphaned 
children in this population should take specific steps to 
address these expectations, including a special emphasis 
on describing what type of healthcare will be included 
and the duration of this healthcare for each patient and 
parent.
Case Ethics
Potential strategies to convey information about 
study procedures, risks, and benefits would include 
using simplified handouts with a basic timeline for 
literate guardians and children. For less literate per-
sons, a verbal explanation should be provided, the 
guardian and child can be asked to repeat back the 
information to clarify comprehension, and studies 
could also provide a pictorial schedule of clinic vis-
its, the timeline of the study, and associated benefits 
such as aid with transportation fees. All case mate-
rials should be translated into both the common 
language and local vernacular, and translators 
should be available at all clinic visits, consents, and 
procedures. 
suBPoPulation economics
Particular attention should be paid to identifying any 
increased risks for subpopulations within this already 
vulnerable group. In Kenya, recent surveys demon-
strated that total orphans, children who have had both 
parents die, were more often found in the poorest 
households, indicating that particular types of orphans 
may be at increased economic disadvantage and thus 
increased vulnerability (UNICEF, 2006). Within a par-
ticular culture, the rights to monetary inheritance and 
property inheritance can also alter the child’s economic 
status significantly. For example, in sub-Saharan Africa, 
there exists a practice of property snatching or stealing 
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property rights from female-headed or child-headed 
households, and this is more likely to affect orphans’ 
households (Wakhweya, 2003; Chipfakacha, 2002). In 
locations where property snatching is prevalent, women 
can be forced out of their home by their deceased 
husband’s family. If both parents are dead, the father’s 
family may claim the property and forcibly expel the 
children, leaving them destitute and on the street. These 
children in turn have significantly decreased resources, 
increased familial stress, and are, as a result, increasingly 
vulnerable to financial pressures or the incentives 
offered by research groups as part of standard practice 
(Subbarao & Coury, 2004). 
Case Ethics
Researchers can address the economic vulnerabilities of 
orphaned children in multiple ways. First, they need to be 
aware of the particular cultural context of the study, 
including social stressors that may not be apparent to 
outside observers. Qualitative inquiry within the com-
munity may be a crucial first step to an understanding of 
the specific context. By increasing awareness of culturally 
biased socioeconomic stressors, the research team can 
guard themselves against unintentional population bias. 
In areas where problems have been identified, for exam-
ple in areas where property snatching is a known occur-
rence, it would be unwise to recruit patients for the 
vaccine study solely using locally established aid centers, 
since the majority of displaced persons in this community 
are women and children. Thus, a thorough understand-
ing of the particular economic vulnerabilities of orphans 
in a particular setting can guide appropriate, protective 
research methods. The precautions needed may vary 
based on the type of research. One could argue that, in a 
case of a simple survey data collection study, neither the 
risks nor the incentives would be of great enough import 
to exclude orphans from the study. However, in the case 
of an HIV vaccine trial, the risks would likely be greater, 
and the financial incentives used may induce economi-
cally deprived, orphaned children to be overly repre-
sented and overly exposed to these risks. Examining a 
community framework with regard to cultural and legal 
characteristics can provide insight into local economic 
policy that influences the study population. 
Psychosocial Vulnerabilities of Orphaned Children in 
Health Research
An orphan’s economic vulnerability is significantly 
related to the psychosocial construct of daily life. 
Psychosocial vulnerabilities of orphans can be classified 
into three main areas of focus: caregiver instability, 
accessibility, and stigma (Table 2).
caregiver instaBility
Orphanhood shapes the cultural structure around the 
child in key ways, most notably in terms of which 
adults are present in the lives of the child, the socioeco-
nomic ramifications of altered family structure, and 
how the child receives care. Orphans frequently have to 
move following the death of one or both parents, creat-
ing an unstable living environment as they change 
caregivers (Young & Ansell, 2003).
The social ramifications from altered family structure, 
unstable living arrangements, and uncertain social 
TABLE 2.  Psychosocial vulnerabilities of orphans.
issue Background relevance Kenya-specific issues Potential intervention
Caregiver 
Instability
Orphans frequently 
have unstable living 
arrangements and 
history of multiple 
caregivers
Unstable living arrange-
ments create tense and 
uncertain social frame-
work leading to increased 
vulnerability
• Grandparents are frequent 
primary caregivers
• Sex of orphan frequently 
determines family place-
ment and involvement
Community healthcare work-
ers can provide insight into 
local social constructs
Accessibility Orphans frequently 
have increased 
home workload and 
decreased school 
attendance
Sample populations often 
drawn from school-aged 
children
Lack of populations such 
as street kids can create 
sample bias if drawn from 
local schools or daycares
• Diversity in population 
recruitment can help 
temporize some bias
• Cautious approach to 
assent with awareness 
of possible educational 
deficiencies
Stigma Specific subpopulations 
are at uniquely higher 
risk
How do you identify, pro-
tect, and appropriately 
include these populations?
Children orphaned from HIV 
have unique stigmatization 
and social isolation
• Awareness of bias in 
existing communities
• Extra precautions in 
confidentiality
• Screening for mental 
health issues
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frameworks increase orphans’ vulnerability. As caregiv-
ers change, the child must adjust to a new home, family, 
rules, and expectations (ibid.). The cultural heritage of 
the child may play a significant role in determining if 
maternal or paternal relatives gain custody of the child. 
Orphans may have a tenuous place within a household 
where their relatives are already under significant finan-
cial or social strains. Orphans also may feel more 
strongly the need to obey the authority figure in charge 
of their living situation, such as the director of a children’s 
home, out of fear and uncertainty of possible displace-
ment, or because it is cultural to obey those in authority. 
Orphans may have few if any options to sustain a living 
if they are kicked out of their adoptive home. These pres-
sures could make a child unlikely to voice any disagree-
ment with a guardian, even if the guardian’s decisions 
place them at risk or discomfort. All these sources of 
stress within a shifting societal framework can create a 
situation where children or the families may seek out 
alternatives means of supporting the family that would 
not have been previously considered. This could create 
a pressure to participate in research, discounting poten-
tial risks and seeking perceived benefits.
Case Ethics
Research across 26 sub-Saharan countries, including Kenya, 
found that care for double orphans varies by gender, with 
boys more likely to be cared for by grandparents and girls 
more likely to live with other relatives (UNICEF, 2006). In 
Kenya, 51% of double orphans and single orphans not living 
with a surviving parent are being raised by grandparents 
(ibid.). The role of grandparents, extended family, or institu-
tions in which orphans may live can have a significant effect 
on children’s ability, willingness, and desire to participate in 
current research. Having more elderly or female caretakers 
not only means that orphans live in households with fewer 
financial resources, but they also may be households that 
lack status within the community (Case, Paxson, & 
Ableidinger, 2002). The combined financial impoverish-
ment and lack of social standing may make orphan caretak-
ers particularly prone to involving their young charges in 
more risky research if either financial gain or healthcare 
options are seen as benefits or if involvement is perceived to 
increase the chance of the child being provided for in other 
ways. Researchers should be aware of potential complica-
tions in custodial arrangements and should require proof of 
guardianship.
accessiBility
Orphans in sub-Saharan Africa bear an increased work-
load within both child-headed households and foster 
families (Subbarao & Coury, 2004). The increased 
workload borne by orphans could alter their participation 
in health research in several ways. Orphans may feel 
increased responsibility to provide for themselves or 
their family, and this could exclude them from research 
participation because they need to work. An increased 
sense of responsibility to provide for themselves and 
their family also may increase the risk of influence by 
potential monetary benefits. Alternatively, as the orphan 
is required to shoulder a larger portion of the family’s 
responsibilities, caregivers may be less inclined to allow 
him or her to participate in a study that would remove 
the child from the workplace for significant amounts of 
time. There may also be a social desirability bias whereby 
guardians may not want a child to participate, or be 
known to researchers, if they are concerned they will get 
in trouble for not taking care of the child or be perceived 
to not be providing adequate care. 
As increased workload can lead to exclusion from stud-
ies due to workforce demands, increased workload can 
also decrease school participation, decreasing orphaned 
children’s exposure to studies and decreasing the likeli-
hood of literacy and educational development necessary 
to understand and participate in a study. Lack of participa-
tion in school places these children at risk for exclusion 
from studies through simple geography. The easiest way 
to survey a population of children and have a consistent 
way of finding the enrolled children for follow-up or fur-
ther treatment is through school enrollment. Orphans are 
at risk of exclusion from such studies as they have higher 
rates of absence from school and lower enrollment 
(UNICEF, 2006). This is consistent with studies which 
have demonstrated that a parent’s financial situation is 
directly related to children’s educational outcomes, and as 
previously discussed, orphans tend to live in poorer 
households (Ntanda et al., 2009). Studies that solely recruit 
from schools in a population with a significant number of 
orphans would have a considerable bias toward under-
representation of orphans. These selection biases might 
threaten the scientific validity of a study if the sickest, 
poorest, or most at-risk subpopulation of children are not 
evaluated along with others of their age. 
In addition to this selection bias, the orphans are also 
vulnerable due to altered educational experience and 
health literacy. For example, investigators may need to 
evaluate the educational resources available and utilized 
when considering a child’s ability to assent. The 
American Academy of Pediatrics guidelines (1995) state 
that seven years is the age at which assent can be 
obtained, based on developmental milestones in chil-
dren. Children who are socially and educationally 
deprived may reach these milestones much later in life. 
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Children who are not in enrolled in school will fall 
behind their peers in their ability to read and write. If 
orphans are to be included in a research study, not only 
must there be consideration for assent procedures with 
regard to educational and developmental level, but lack 
of participation in schooling must be acknowledged as 
a potential selection bias. In addition, the culture of chil-
dren not questioning decisions made by the guardians 
may influence the ability of a child to assent.
Case Ethics
In our HIV vaccine trial, for example, frequent labora-
tory monitoring would be required and may be inconve-
nient for a family who relies on the orphan’s work. 
Attempting to work with families to arrange for conve-
nient testing sites within local communities and flexible 
hours of clinic offices based on community needs and 
work schedules may help to improve this outcome. An 
agricultural-based community, for example, would likely 
have a better response rate if clinic hours were held after 
prime working hours or if the vaccination schedule 
could be targeted to fall outside of peak harvest times. 
While alternative methods for explaining projects and 
signing documents can be designed, it is important to 
consider the educational limitations of the study proto-
col when including orphans. The explanation of a com-
plicated scientific concept through pictures or movies 
may be done, as in the case of an HIV vaccine, but it 
requires extra investment from the research team. If 
orphans are to be included in a research study, not only 
must there be consideration for assent procedures with 
regard to educational and developmental level, but lack 
of participation in schooling must be acknowledged as 
a potential selection bias with orphans underrepresented 
in a sample drawn from schools. 
stigma
Orphans’ exposure to abuse, increased stress, and stigma 
attached to certain subpopulations of orphans are addi-
tional psychosocial vulnerabilities that must be considered 
for ethical health research participation. The increased 
isolation that accompanies orphans’ shifting social frame-
work and stigmatization can lead to increased risk of 
exploitation and abuse. Studies from Malawi indicate an 
increased risk of abuse with orphanhood (Muhwezi, 
Muhangi, & Mugumya, 2009). Certain orphan popula-
tions may face additional burdens. In South Africa and 
Namibia, orphans who live on the streets have increased 
exposure to prostitution, drug abuse, HIV, and crime, 
compounding their traumatic experiences (American 
Academy of Pediatrics, 1995; Subbarao & Coury, 2004). 
While the subpopulation of street children in research 
requires additional considerations for research inclusions 
that are beyond the scope of this paper, exposure to high-
risk activities and settings are significant vulnerabilities in 
orphans. While these increased risks contribute to orphans’ 
vulnerabilities, they also provide an argument for their 
inclusion in health research. Orphans’ increased risk for 
contracting HIV is precisely why orphans should be 
included in research related to HIV, particularly research 
related to vaccine prevention strategies from which this 
population could greatly benefit. While the risks of vac-
cine trial participation are typically considered greater 
than minimal risks, the risk for HIV infection in orphans’ 
daily life is significantly higher. Thus, the argument could 
be made that adolescents approaching majority age should 
be able to assent to participation in such a study. 
The psychological status of orphans, and the associated 
vulnerabilities, are also influenced by how they became 
orphans. In Kenya, large numbers of children are orphaned 
by AIDS every year. Children orphaned by AIDS may be 
singled out at school, experiencing stigma and bullying 
more than other orphans and non-orphans, both of which 
directly correlate with their mental health (Subbarao & 
Coury, 2004; Boris et al., 2006). Children orphaned by 
AIDS are also more likely to suffer from post-traumatic 
stress disorder, recurrent trauma, anxiety, and depression, 
to perform more poorly in school, and to lack self-esteem 
compared to other orphans (Pelton & Forehand, 2005; 
Bhargava, 2005). Studies from Rwanda and Mozambique 
have cited orphanhood as an independent risk factor for 
increased depression and social isolation (Boris et al., 2006). 
Thus, the psychological well-being of the child and the 
mental health of the population involved should be closely 
examined and plans enacted to either exclude at-risk par-
ticipants or provide support to ensure that no further harm 
is caused. Support provided may include psychological 
counseling, social services support, or care extended to psy-
chiatric medicine. Studies from Zimbabwe have associated 
orphanhood with increased stress directly related to 
decreased social support (Gilborn et al., 2006). 
The stigma associated with HIV/AIDS is significant, 
which also impacts how recruiting, confidentiality, and 
maintenance of records within the study are handled. 
Even for a prevention trial for a vaccine, it is critical to 
consider any possible social ramifications for these chil-
dren in being associated with such a controversial disease. 
The stigma that could be associated with participating in 
an HIV-related trial requires extra protections for their 
confidentiality. In a population with an already elevated 
risk of isolation and accompanying mental health issues, 
the stigma attached to being associated with an HIV trial 
could be significant and detrimental.
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Case Ethics
As a researcher, it is crucial to be aware of such comorbidities 
in a study population, as they render the children more 
vulnerable. To adhere to the principle of nonmaleficence, 
a researcher needs to be aware of how orphaned subjects 
might be at more risk from psychological trauma or from 
being further stigmatized. Depression scales or other 
mental health screening tools may be of great use to 
researchers to identify orphans who may be particularly 
vulnerable and subsequently provide additional support, 
such as additional counseling or community resources, for 
participants. In considering the orphan population for 
inclusion in a vaccine trial, for example, depression or 
social isolation might make orphaned children more will-
ing to discount risks to themselves or to overvalue a per-
ceived social benefit from study participation.
Physical Vulnerabilities of Orphaned Children in  
Health Research
Physical health, as well as mental health, plays a significant 
role in the vulnerabilities of orphans related to their 
developmental stage, differential access to healthcare, 
and adherence to healthcare routines (Table 3).
develoPment
Children are rendered vulnerable because of their devel-
opmental process. Because of their developmental imma-
turity, in most settings, young children cannot provide 
legally authorized informed consent for their own treat-
ment or for participation in research. Moreover, children 
lack resources such as money or property that would give 
them more socioeconomic power. Medically, children 
have unique parameters for physiologic and psychologi-
cal development that change constantly with age and 
growth, creating an additional set of vulnerabilities. 
Infants can be at greater risk of harm from particular 
medications or treatments due to physiologic immaturity 
in how they metabolize medicines or respond to a given 
therapy, altering the risks and benefits balance they 
would experience in clinical research. School-age chil-
dren begin to develop a sense of the permanence of 
death, influencing their ability to weigh the risks and 
benefits of a particular course of action. Adolescents are 
transitioning to physical maturity while still displaying a 
risk-taking profile that varies significantly from adults. 
While these are not unique vulnerabilities of orphans, 
the real versus presumed developmental stage of each 
orphan must be taken into consideration. Physiologically, 
nutritionally deprived bodies will not metabolize medi-
cations or tolerate treatments in the same manner as 
healthy organ systems. Thus, evaluation of children for 
both psychological and physiological development is 
crucial prior to initiation of a study. 
diagnosis and treatment
Orphans may be less likely to access healthcare services. 
The orphans’ role in the family and relationship with 
their caregiver have been associated with differential 
presentation to health clinics, government-run institu-
tions, and traditional healers. Orphanhood in Uganda 
and Kenya has been shown to predict delayed access to 
healthcare, with orphans with HIV receiving antiretrovi-
ral therapy at an older age and, in Ugandan studies, with 
more advanced disease (Ntanda et al., 2009; Nyandiko, 
TABLE 3.  medical vulnerabilities of orphans.
issue Background relevance Kenya-specific issues Potential intervention
Presentation of Illness Orphans frequently 
present later in 
disease process for 
medical treatment
Later presentation 
can create medical 
dilemmas, possibly 
excluding orphans 
from research
Children presenting 
later to HIV clinics for 
treatment have more 
complicating opportu-
nistic infections
Clear guidelines for 
admittance to studies 
allowing for varying 
presentations at time 
of enrollment
Treatment Facility Orphans present 
at local clinics, 
whereas non-
orphaned children 
have a wider range 
of presenting 
locations
Surveying only large 
tertiary care centers 
creates population 
bias
Systems such as 
AMPATH in west-
ern Kenya allow for 
greater access to a 
varied population with 
both urban and rural 
clinics
Diversity in sampling 
practices through 
site variance
Follow-up/ Supervision Unstable social 
constructs create 
barriers to effec-
tive follow-up and 
supervision
Being an orphan has 
been associated with 
worse medication 
adherence but better 
clinic attendance in 
children infected with 
HIV
Adherence trials done 
with HIV medications 
demonstrate that 
social-cultural net-
work is imperative to 
assuring adherence
Assessing available 
caregivers and 
enhancing support 
service for retention 
in care and research
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Ayaya, & Nabakwe, 2006). In addition, Deininger et al. 
(2003) have shown that children in foster care have sig-
nificantly less access to healthcare services, and a signifi-
cant increase in the number of days of being sick prior to 
seeking treatment for orphans. Delays in seeking health-
care also have a significant effect on the health status of 
children presenting for research studies. Sicker children 
and their families may be more likely to agree to partici-
pation in research out of desperation, but they also may 
be more vulnerable to any health risks from research 
participation. 
Case Ethics
Clear inclusion and exclusion criteria for the proposed 
study are vital, as well as to consider recruiting strategies 
that will reach children who may not have regular access 
to the healthcare system. In addition, it would be benefi-
cial to outline how the study will address the varying pre-
sentations of orphans at the time of enrollment, as well as 
plans to meet the health needs of any study participants. In 
the HIV vaccine trial, it would be important to consider 
the time delay with seroconversion post-exposure and 
how to minimize delays in diagnosis among children who 
might be less likely to return to the clinic. 
adherence
Not only are orphans sicker at presentation, but issues of 
adherence to treatment can become a significant issue 
without parental involvement. Relationship dynamics 
play a crucial role in adherence to treatment protocols 
and follow-up healthcare visits. In other work by Vreeman 
et al. (2009), the presence of “an enabling cultural-social 
fabric” was the key to the care of children, including pedi-
atric medication adherence, in a setting such as Kenya. 
The caregiving structures for orphans may play very dis-
tinct roles for issues such as taking medicines or bringing 
a child to clinic; in previous work in Kenya, being an 
orphan was associated with worse medication adherence 
among HIV-infected children, but with more consistent 
clinic attendance (Vreeman et al., 2008). Considering an 
intervention with long-term outcomes, such as an HIV 
vaccine trial, the ability to continue to participate in fol-
low-up care and continued health monitoring should be 
carefully considered. 
Case Ethics
The social support that orphans do or do not receive 
over time can have a critical impact on their health and 
well-being when participating in biomedical research. 
Providing these children with additional resources such 
as transportation reimbursement for clinic visits may 
help to improve clinic visit show rates. Concordantly, 
medication adherence could be increased by simplify-
ing dosing regimens and using packaging appropriate 
for children and people who may be illiterate. 
conclusion
Pediatric orphans are a vulnerable population due to 
decreased economic resources, psychosocial instability, 
increased risk of abuse, and delayed/decreased access to 
healthcare. These vulnerabilities are significant, and they 
have the potential to affect the orphans’ ability, willing-
ness, and likelihood to participate in biomedical research. 
For researchers, these vulnerabilities are an additional set 
of concerns that must be addressed in a population-
specific manner to ethically include or exclude participa-
tion. Precautions need to be taken to protect orphans 
and to address these vulnerabilities when developing 
protocols for health research in settings with large 
orphan populations. By carefully considering each issue 
in a population- and study-specific manner, researchers 
can make valuable contributions to the overall health 
and well-being of this uniquely vulnerable population. 
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